Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure Limited (NASDAQ:NVCR – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 7,580,000 shares, a drop of 17.7% from the August 31st total of 9,210,000 shares. Based on an average daily trading volume, of 1,760,000 shares, the short-interest ratio […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The […]
HC Wainwright lowered shares of NovoCure (NASDAQ:NVCR – Free Report) from a buy rating to a neutral rating in a report issued on Monday morning, MarketBeat.com reports. HC Wainwright currently has $25.00 target price on the medical equipment provider’s stock, down from their prior target price of $85.00. HC Wainwright also issued estimates for NovoCure’s […]
NovoCure (NASDAQ:NVCR – Get Free Report) had its price target decreased by equities researchers at Wells Fargo & Company from $102.00 to $49.00 in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price target indicates a potential upside of […]
-- Health care stocks were steady to higher late Monday afternoon with the NYSE Health Care Index adding 0.1% and the Health Care Select Sector SPDR Fund little changed. The iShares Biotechnology...